SCHEMBL2199519

SCHEMBL2199519

CNC(=O)COc1ccc(F)c(C(=O)c2ccc(Nc3ccc(Cl)cc3C)cc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 6/20 0.51
MAPK12 P53778 6/20 0.51
MAPK11 Q15759 6/20 0.51
MAPK14 Q16539 6/20 0.51
SYK P43405 4/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
THRB P10828 1/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.42
KCNH2 Q12809 1/20 0.41
POLB P06746 1/20 0.41
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200571 0.88 MAPK13 (0.50) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL2201685 0.86 MAPK14 (0.52) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL2199484 0.83 MAPK14 (0.49) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2196274 0.81 MAPK13 (0.59) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL2199752 0.79 MAPK14 (0.61) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2201715 0.79 MAPK14 (0.51) MAPK13MAPK12MAPK11MAPK14
SCHEMBL5988678 0.76 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL1907242 0.74 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL2198903 0.74 MAPK14 (0.71) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL1906099 0.72 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.